| |
|
|
|
Adial Pharmaceuticals Inc.  
|
|
1.96 -0.05 (-0.02%) |
07-19 16:00 |
|
Open: |
1.95 |
Pre close: |
2.01 |
Target:
|
2.51 
|
|
High: |
2.03 |
Low: |
1.9 |
Resistance:
|
2.15
2.51
|
|
Volume: |
13,726 |
Market Cap: |
20M |
Support:
|
1.83
1.64
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.99
|
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
1.88 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.53 |
Stochastic Oscillator |
%K(14,3):
|
68.63 |
|
MA(250): |
0.00 |
%D(3): |
71.39 |
|
Average Volume(K) |
3-Month: |
7016
|
52-Week |
High:
|
9.44 |
|
10-Days: |
4181 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
50.58 |
Change(%): |
-51.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.321 |
Return on Equity (ttm) |
-267.4 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-76.6 |
Shares Float (M) |
6.44 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
35.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.68 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
121 |
|
Book Value (p.s.) |
1.150 |
EBITDA (p.s.) |
-0.727 |
P/E |
-0.84 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.70 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.01 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-0.17 |
P/CF |
-0.00 |
|
|
|
|
|
|
